eCite Digital Repository

Glycopeptides and antibiotics for Gram-Positive Bacterial Infections

Citation

Zaidi, STR and Janson, B, Glycopeptides and antibiotics for Gram-Positive Bacterial Infections, Drug Dosing in Obesity - Volume 1: Antimicrobials, Springer, STR Zaidi & JA Roberts (ed), Switzerland, pp. 63-76. ISBN 978-3-319-44034-7 (2016) [Research Book Chapter]

Copyright Statement

Copyright 2016 Springer International Publishing Switzerland

DOI: doi:10.1007/978-3-319-44034-7_7

Abstract

Glycopeptides, lipopetides and other antibiotics such as linezolid and quinupristin/dalfopristin, are exclusively used for the treatment of infections caused by Gram-Positive Bacteria. Limited information is available about the dosing of these antibiotics in obese patients. This chapter aims to summarise the available evidence on the dosing of glycopeptides, lipopeptides, linezolid and quinupristin/dalfopristin in obesity. Specific dosing recommendations are also provided to aid clinical decisions making with regards to dosing of these antibiotics in obese patients.

Item Details

Item Type:Research Book Chapter
Keywords:vancomycin, daptopmycin, glycopeptides, lpopeptides, linezolid, quinupristin/dalfopristin, obese, dosing
Research Division:Biomedical and Clinical Sciences
Research Group:Clinical sciences
Research Field:Infectious diseases
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Zaidi, STR (Dr Tabish Razi Zaidi)
ID Code:110369
Year Published:2016
Deposited By:Pharmacy
Deposited On:2016-07-25
Last Modified:2017-10-23
Downloads:0

Repository Staff Only: item control page